New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
14:09 EDTESALYEisai carcinoma treatment granted FDA orphan designation
According to a post on the FDA's website, Eisai's lenvatinib for the treatment of hepatocellular carcinoma has been granted orphan designation. Reference Link
News For ESALY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2016
18:52 EDTESALYEisai to supply ingredients to generic drug makers, Nikkei says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use